Company
AsclepiX Therapeutics
| Industry | clinical-stage biotech company leveraging computational biology to develop peptides for improved treatments of retinal diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| AsclepiX Therapeutics | Series A-3 Funding | 2023-07-26 |